Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Reports Flat Q4 Sales as Thermal Cycler Injunction Took Its Toll

NEW YORK, Feb. 23 (GenomeWeb News) - Bio-Rad yesterday said that fourth-quarter net sales were flat, with $307.3 million for the period ended Dec. 31, compared to $307.9 in the year-ago period.

 

Net sales show a 2.9-percent rise from the similar period in 2004 when earnings are adjusted for currency-exchange effects, the company said.

 

The company's Life Science segment experienced a 5.3-percent drop in net sales, which fell to $140.7 million from $148.6 million in the fourth quarter of 2004. Bio-Rad attributed the decline to an injunction that halted the sale and manufacture of its MJ Research thermal cyclers..

 

Bio-Rad's Clinical Diagnostics segment reported net sales of $162.9 million for the period ended Dec. 31, a rise of 4 percent year over year.

 

R&D expenses remained nearly unchanged at $31.9 million for the current period, versus $31.1 million in the year-ago period.

 

Net income decreased to $13.5 million in the fourth quarter from $17.1 million in 2004.

 

The company had around $296.7 million in cash and equivalents as of Dec. 31.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.